English Abstract
Journal Article
Add like
Add dislike
Add to saved papers

[Skin cancers in Togo: a 223-case series].

OBJECTIVES: The aim of this retrospective study was to determine the relative frequency and trends of skin cancers in Togo.

METHOD: The records of patients with primitive skin cancers diagnosed in the pathology laboratory of Lomé teaching hospital from 1994 to 2005 were reviewed.

RESULTS: During the study period, 223 cases of skin cancers were recorded. The overall mean patient age and male-to-female ratio were 42 +/- 17 years and 1.56 respectively. The most common forms of skin cancers observed were Kaposi's sarcoma in 103 cases (46.2%), skin carcinoma in 75 cases (33.6%), melanoma in 23 cases (10.3%), and dermatofibrosarcoma protuberans in 16 cases (7.2%). In the Kaposi's syndrome group, the average age and male-to-female ratio were 39 +/- 15 years and 2.68 respectively and the main location was the lower limbs (77.9%). In the cutaneous carcinoma group, 64 cases involved squamous cell carcinoma with an average age and male-to-female ratio of 48 +/- 17 years and 1.29 respectively. In 18 cases squamous cell carcinoma developed on chronic leg ulcer. In the melanoma group, the average age and male-to-female ratio were 55 +/- 16 years and 0.64 respectively and the main location was the distal extremities. In the dermatofibrosarcoma protuberans group, the average age and male-to-female ratio were 45 +/- 20 years and 0.78 respectively. The other types of skin cancers observed were mycosis fongoides in 4 cases (1.8%) and Paget's disease in 2.

CONCLUSION: This study showed that Kaposi's sarcoma was the most frequent skin cancer in Togo in conjunction with the current HIV infection epidemic. Findings also indicated that the incidence of other types of skin cancers was relatively stable.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app